EDITAS MEDICINE, INC. Debt Securities, Available-for-sale
EDITAS MEDICINE, INC. (EDIT) had Debt Securities, Available-for-sale of $211.65 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale $211.65M.
- 2026-03-31: Debt Securities, Available-for-sale $123.65M.
- 2025-12-31: Debt Securities, Available-for-sale $146.65M.
- 2025-09-30: Debt Securities, Available-for-sale $165.65M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $211.65M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $123.65M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $146.65M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $165.65M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $178.50M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $220.96M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $269.91M 10-K · filed 2026-03-09 |
| 2024-09-30 | $265.09M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $318.31M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $376.78M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $427.13M 10-K · filed 2025-03-05 |
| 2023-09-30 | $446.41M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $480.03M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $401.78M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $437.37M 10-K · filed 2024-02-28 |
| 2022-09-30 | $478.46M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $527.62M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $566.41M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $619.92M 10-K · filed 2023-02-22 |
| 2021-09-30 | $657.04M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $698.14M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $723.22M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $511.77M 10-K · filed 2022-02-24 |
| 2020-09-30 | $541.29M 10-Q · filed 2020-11-06 |
| 2019-12-31 | $238.18M 10-K · filed 2021-02-26 |
| 2018-12-31 | $372.38M 10-K · filed 2019-03-01 |
| 2018-09-30 | $340.92M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $347.50M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $358.57M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $329.14M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |